Current Search Criteria:
Intervention: Dengue 1,2,3,4 (attenuated) vaccine
Found 38 matching trials
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
PHASE1Dengue fever, caused by dengue viruses, is a major health problem in the tr...
Location
Center for Immunization Research
Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine
PHASE1Dengue fever, caused by dengue viruses, is a major health problem in tropic...
Location
Center for Immunization Research, Johns Hopkins School of Public Health
A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children
PHASE1One year follow-up on immunogenicity and safety of a booster dose of DEN va...
Location
Department of Pediatrics, Phramongkutklao Hospital
Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
PHASE3The purpose of this study was to evaluate the safety and immunogenicity of ...
Location
Multiple Locations
Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India
PHASE2The aim of this study is to evaluate the immunogenicity and safety of the C...
Location
Multiple Locations
Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
PHASE1West Nile (WN) virus infection is an emerging disease. Infection with WN vi...
Location
Center for Immunization Research, Johns Hopkins School of Public Health (DC Location)
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
PHASE1Dengue viruses can cause dengue fever and other serious health conditions, ...
Location
Center for Immunization Research, Johns Hopkins School of Public Health
A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan
PHASE2Dengue fever is caused by an infection with the dengue virus. Vaccination w...
Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine
PHASE1Background:
Dengue is a disease caused by a virus transmitted by mosquitoe...
Location
National Institutes of Health Clinical Center
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America
PHASE3The aim of the study was to assess the efficacy of Sanofi Pasteur's CYD den...
Location
Multiple Locations